Clinical trial
The Use of the UroShield Device in Patients With Indwelling Urinary Catheters
NCT00446732 · Nanovibronix, Industry · Unknown status
Key facts
| NCT number | NCT00446732 |
|---|---|
| Title | The Use of the UroShield Device in Patients With Indwelling Urinary Catheters |
| Official title | Catheter Associated Urinary Tract Infections |
| Acronym | CAUTI |
| Lead sponsor | Nanovibronix, Industry |
| Collaborators | Shaare Zedek Medical Center |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Tract Infection |
| Intervention type | Device |
| Interventions | UroSshield |
| Enrollment | 200 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Mar 13, 2007 |
| Last update posted | Mar 25, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: